Dermot McGovern, MD, PhD, director of Translational Research in the F. Widjaja Inflammatory Bowel Disease Institute at Cedars-Sinai, has been awarded the prestigious Sherman Prize for his pioneering work in advancing understanding of the genetic architecture of inflammatory bowel disease (IBD) and applying that knowledge to deliver personalized medicine to patients.